Chris Robillard
Corporate Officer/Principal en CRINETICS PHARMACEUTICALS, INC. .
Cargos activos de Chris Robillard
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/03/2022 | - |
Historial de carrera de Chris Robillard
Antiguos cargos conocidos de Chris Robillard.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formación de Chris Robillard.
Lehigh University | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Robillard
- Experiencia